Diabetomics, Inc.

HILLSBORO, OR · Founded 2008 · Medtech · Private

Advanced data science and molecular diagnostics platform for disease detection and understanding

Claim this profile

Follows are private to you and power your alerts

Updated · modalitydx.com

Sector
Medtech
Headquarters
HILLSBORO, OR
Founded
2008
Latest Form D
$2.5M, Nov 2014
Total capital
$6M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$6M
2 Form D · last Nov 2014
144 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
4 pending · first 2025
Rank in peer group#29 of 73

Capital timeline

2011201220132014FEDERAL ↑EQUITY ↓Cumulative $6M1st Form D$3.5M2nd Form D$2.5M
2011201220132014FEDERAL ↑EQUITY ↓Cumulative $6M1st Form D$3.5M2nd Form D$2.5M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$2.5M
  • Private capital raisedForm D · SEC · 1st filing$3.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 73 peers

Line = median

Medtech · Platform

  • Granted patents#29 · top 40%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Srinivasa Rao NagallaResearcherExecutive Officer, Director, PromoterLinked by 1 patent
  • Chris Rao DudleyDirectorNamed in SEC Form D filings
  • Dave Rao GundersonExecutive Officer, DirectorNamed in SEC Form D filings
  • Rick Rao MillerDirectorNamed in SEC Form D filings
  • Robert Rao GooteeDirectorNamed in SEC Form D filings
  • Robert Rao GreggDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 5
Show all 5 patent records
  • Systems And Methods For Rheumatoid Arthritis Biomarker DetectionAug 21, 2025 · Application 19204357Pending
  • Systems And Methods For Rheumatoid Arthritis Biomarker DetectionMay 13, 2025 · US 12,298,302Granted
  • Systems And Methods For Rheumatoid Arthritis Biomarker DetectionApplication PCTUS2021062928Pending
  • Systems And Methods For Rheumatoid Arthritis Biomarker DetectionApplication 63123919Pending
  • Biomarkers For Assessment Of PreeclampsiaApplication PCTUS2015041796Pending
  • Hyperion Surgical, Inc.Similar federal contract value in Medtech · null in contracts
  • Oncotect Inc.Similar federal contract value in Medtech · null in contracts
  • Beeken BioMedical, LLCSimilar federal contract value in Medtech · null in contracts
  • BIOSCALE INCSimilar federal contract value in Medtech · null in contracts
  • Bioceptive, Inc.Similar federal contract value in Medtech · null in contracts
  • Novaerus Group LtdSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .